The Prospect of Pandemic Influenza: Why Should the Optometrist Be Concerned About a Public Health Problem?

Overview

Journal Optometry

Specialty Ophthalmology

Date 2007 Dec 7

PMID 18054133

Citations 2

Authors

Gregory G Hom

A Paul Chous

Affiliations

Soon will be listed here.

Abstract

Background: Optometrists are uniquely placed in the health care field because they provide both services as well as goods to patients. In the event of an influenza pandemic, optometrists may be challenged with a host of issues, including impediments to clinical patient care, manufacture and delivery of ophthalmic devices, and maintaining business continuity and infection control.

Overview: This report reviews pandemic influenza, the effect of a pandemic event on business survival, and response measures for the primary eye care provider. The ethical and legal issues surrounding control of a pandemic influenza and the prospect of telemedicine as a form of social distancing are also discussed.

Conclusions: Knowledge of the pharmacologic and nonpharmacologic measures to control a pandemic influenza will help prepare the eye care provider for addressing challenges to patient care and business continuity in the face of a highly contagious disease. Understanding the legal and ethical issues that arise during a pandemic event will help optometrists make informed choices as health care professionals and as citizens.

Citing Articles

The biopsychosociotechnical model: a systems-based framework for human-centered health improvement.

Card A Health Syst (Basingstoke). 2024; 12(4):387-407.

PMID: 38235298 PMC: 10791103. DOI: 10.1080/20476965.2022.2029584.

Challenges and impact of COVID-19 lockdown on Indian optometry practice: A survey-based study.

Karthikeyan S, Nandagopal P, R V, Nayak A J Optom. 2021; 15(2):145-153.

PMID: 33414101 PMC: 7762711. DOI: 10.1016/j.optom.2020.10.006.

References

Simonsen L, Clarke M, Schonberger L, Arden N, Cox N, Fukuda K . Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998; 178(1):53-60. DOI: 10.1086/515616. View

Moser M, Bender T, Margolis H, Noble G, Kendal A, RITTER D . An outbreak of influenza aboard a commercial airliner. Am J Epidemiol. 1979; 110(1):1-6. DOI: 10.1093/oxfordjournals.aje.a112781. View

Cauchemez S, Boelle P, Thomas G, Valleron A . Estimating in real time the efficacy of measures to control emerging communicable diseases. Am J Epidemiol. 2006; 164(6):591-7. DOI: 10.1093/aje/kwj274. View

Ruderman C, Tracy C, Bensimon C, Bernstein M, Hawryluck L, Shaul R . On pandemics and the duty to care: whose duty? who cares?. BMC Med Ethics. 2006; 7:E5. PMC: 1459179. DOI: 10.1186/1472-6939-7-5. View

Gurwood A, Drake J . Guillain-Barré syndrome. Optometry. 2006; 77(11):540-6. DOI: 10.1016/j.optm.2006.06.014. View

Christian M, Hawryluck L, Wax R, Cook T, Lazar N, Herridge M . Development of a triage protocol for critical care during an influenza pandemic. CMAJ. 2006; 175(11):1377-81. PMC: 1635763. DOI: 10.1503/cmaj.060911. View

Oxford J, Lambkin R, Elliot A, Daniels R, Sefton A, Gill D . Scientific lessons from the first influenza pandemic of the 20th century. Vaccine. 2006; 24(44-46):6742-6. DOI: 10.1016/j.vaccine.2006.05.101. View

Kilbourne E . Influenza pandemics of the 20th century. Emerg Infect Dis. 2006; 12(1):9-14. PMC: 3291411. DOI: 10.3201/eid1201.051254. View

LESTER Jr W . The influence of relative humidity on the infectivity of air-borne influenza A virus, PR8 strain. J Exp Med. 1948; 88(3):361-8. PMC: 2135823. DOI: 10.1084/jem.88.3.361. View

10.

Medema J, Zoellner Y, Ryan J, Palache A . Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply. Virus Res. 2004; 103(1-2):9-15. DOI: 10.1016/j.virusres.2004.02.006. View

11.

Hogg W, Huston P . Controlling droplet-transmitted respiratory infections: best practices and cost. Can Fam Physician. 2007; 52(10):1229-32. PMC: 1783603. View

12.

Fredette M, De Serres G, Malenfant M . Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination. Clin Infect Dis. 2003; 37(8):1136-8. DOI: 10.1086/378294. View

13.

Scuffham P, West P . Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine. 2002; 20(19-20):2562-78. DOI: 10.1016/s0264-410x(02)00154-8. View

14.

Monto A, Gravenstein S, Elliott M, Colopy M, Schweinle J . Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000; 160(21):3243-7. DOI: 10.1001/archinte.160.21.3243. View

15.

Nicholson K . Clinical features of influenza. Semin Respir Infect. 1992; 7(1):26-37. View

16.

Halloran M, Hayden F, Yang Y, Longini Jr I, Monto A . Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol. 2006; 165(2):212-21. DOI: 10.1093/aje/kwj362. View

17.

Taubenberger J, Reid A, Lourens R, Wang R, Jin G, Fanning T . Characterization of the 1918 influenza virus polymerase genes. Nature. 2005; 437(7060):889-93. DOI: 10.1038/nature04230. View

18.

Liao C, Chang C, Liang H . A probabilistic transmission dynamic model to assess indoor airborne infection risks. Risk Anal. 2005; 25(5):1097-107. DOI: 10.1111/j.1539-6924.2005.00663.x. View

19.

Moscona A . Neuraminidase inhibitors for influenza. N Engl J Med. 2005; 353(13):1363-73. DOI: 10.1056/NEJMra050740. View

20.

Longini Jr I, Halloran M . Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol. 2005; 161(4):303-6. DOI: 10.1093/aje/kwi053. View